SEI Investments
PCVX icon

SEI Investments’s Vaxcyte PCVX Stock Holding History

SEI Investments’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95M Sell
33,516
-29
-0.1% -$1.57K ﹤0.01% 1968
2026
Q1 		$1.95M Buy
33,545
+2,605
+8% +$141K ﹤0.01% 2022
2025
Q4 		$1.43M Sell
30,940
-59,008
-66% -$2.64M ﹤0.01% 2016
2025
Q3 		$3.24M Buy
89,948
+50,239
+127% +$1.66M ﹤0.01% 1490
2025
Q2 		$1.29M Sell
39,709
-142,194
-78% -$4.66M ﹤0.01% 1815
2025
Q1 		$6.87M Buy
181,903
+20,221
+13% +$1.62M 0.01% 1139
2024
Q4 		$13.2M Sell
161,682
-17,535
-10% -$1.74M 0.02% 864
2024
Q3 		$20.5M Buy
179,217
+9,068
+5% +$817K 0.03% 653
2024
Q2 		$12.8M Buy
170,149
+66,746
+65% +$4.54M 0.02% 813
2024
Q1 		$7.06M Buy
103,403
+55
+0.1% +$3.81K 0.01% 1044
2023
Q4 		$6.49M Sell
103,348
-18,071
-15% -$939K 0.01% 1066
2023
Q3 		$6.19M Buy
121,419
+55,637
+85% +$2.74M 0.01% 1069
2023
Q2 		$3.29M Buy
65,782
+43,955
+201% +$2.08M 0.01% 1402
2023
Q1 		$818K Sell
21,827
-316
-1% -$13.4K ﹤0.01% 1953
2022
Q4 		$1.06M Buy
+22,143
New +$869K ﹤0.01% 1733

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

SEI Investments's PCVX Position: Q2 2026 in Review

SEI Investments reduced its Vaxcyte (PCVX) stake by 0.09% in Q2 2026, selling an estimated $1.57K and leaving 33,516 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1968.

SEI Investments first reported a position in PCVX in Q4 2022 and has held it in 15 quarters since. The position peaked at $20.5M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • SEI Investments held 33,516 shares of Vaxcyte worth $1.95M as of Q2 2026.
  • SEI Investments sold 29 Vaxcyte shares in Q2 2026, an estimated $1.57K.
  • Vaxcyte made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #1968 holding.
  • SEI Investments first reported a position in Vaxcyte in Q4 2022 and has held it in 15 quarters since.
  • SEI Investments's Vaxcyte position peaked at $20.5M in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.